HLA
AXNX

Hamilton Lane Advisors’s Axonics, Inc. Common Stock AXNX Stock Holding History

Hamilton Lane Advisors’s Portfolio AXNX Stock Details AXNX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q1 		– Sell
-10,109
Closed -$566K – 99
2021
Q4 		$566K Buy
+10,109
New +$618K 0.07% 66

Other funds holding AXNX

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BG
Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return
CS
Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return
Axa
Axa Paris, France $256M AUM 25.01% 1-Year Est. Return
RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
BAMCO Inc
BAMCO Inc New York $33.1B AUM 11.16% 1-Year Est. Return
Loomis, Sayles & Company
Loomis, Sayles & Company Boston, Massachusetts $74.3B AUM 24.01% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return

Hamilton Lane Advisors's AXNX Position: Q1 2022 in Review

Hamilton Lane Advisors sold out of Axonics, Inc. Common Stock (AXNX) in Q1 2022, closing a stake of 10,109 shares — an estimated $566K sold.

Hamilton Lane Advisors first reported a position in AXNX in Q4 2021 and held it in 1 quarter. The position peaked at $566K in Q4 2021. 186 funds tracked by Wall St. Rank hold AXNX as of Q1 2022.

  • Hamilton Lane Advisors reported no remaining Axonics, Inc. Common Stock position as of Q1 2022 after selling out during the quarter.
  • Hamilton Lane Advisors sold 10,109 Axonics, Inc. Common Stock shares in Q1 2022, an estimated $566K.
  • Hamilton Lane Advisors first reported a position in Axonics, Inc. Common Stock in Q4 2021 and held it in 1 quarter.
  • Hamilton Lane Advisors's Axonics, Inc. Common Stock position peaked at $566K in Q4 2021.
  • 186 funds tracked by Wall St. Rank held Axonics, Inc. Common Stock as of Q1 2022.

Based on Hamilton Lane Advisors's 13F filing for Q1 2022, filed 4 May 2022.